| abstract |
Use of an α-2-adrenoceptor antagonist that is selective forncc-2C adrenoceptor subtype or as a derivative for productionnmedicaments for treating mammals suffering from mental illnessnstress-induced propagation. Mental illness cannsuch as anxiety, stress, post-traumatic diseasenstress, affective flatness, anhedonia, alogy,nAbuse, aggression or cognitive impairmentninitiated by stress-induced neuronal degeneration.nIn addition, the drug may contain a second combinationna therapeutically active compound and anxiolytic,nantidepressant or antipsychotic effect or itsna derivative, wherein the combination may be in common formna dosage form or kit. |